Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[Research on quality registries provides clinical benefit. Results from the National Prostate Cancer Registry].

Wirén S, Stattin P.

Lakartidningen. 2012 Jun 27-Jul 17;109(26-28):1294-7. Swedish. No abstract available.

PMID:
22852260
2.

Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden.

Van Hemelrijck M, Garmo H, Holmberg L, Stattin P, Adolfsson J.

Eur Urol. 2012 Apr;61(4):690-700. doi: 10.1016/j.eururo.2011.09.010. Epub 2011 Sep 17.

PMID:
21945719
3.

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.

Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J; National Prostate Cancer Register (NPCR) of Sweden.

J Natl Cancer Inst. 2010 Jul 7;102(13):950-8. doi: 10.1093/jnci/djq154. Epub 2010 Jun 18.

4.

Re: Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.

Stattin P, Garmo H, Steineck G, Bill-Axelson A.

J Natl Cancer Inst. 2010 Sep 22;102(18):1447-8; author reply 1448. doi: 10.1093/jnci/djq307. Epub 2010 Aug 12. No abstract available.

PMID:
20705934
5.

Tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.

Ladjevardi S, Sandblom G, Berglund A, Varenhorst E.

Eur Urol. 2010 Apr;57(4):631-8. doi: 10.1016/j.eururo.2009.03.007. Epub 2009 Mar 10.

PMID:
19299069
6.

Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.

Berglund A, Garmo H, Robinson D, Tishelman C, Holmberg L, Bratt O, Adolfsson J, Stattin P, Lambe M.

Eur J Cancer. 2012 Jan;48(1):75-84. doi: 10.1016/j.ejca.2011.07.009. Epub 2011 Aug 16.

PMID:
21852113
7.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. Epub 2007 Oct 9.

PMID:
17925537
8.

Does the benefit justify the risk?

Albertsen PC.

J Natl Cancer Inst. 2010 Jan 6;102(1):4-5. doi: 10.1093/jnci/djp427. Epub 2009 Dec 7. No abstract available.

PMID:
19996059
9.

Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.

Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P.

Eur Urol. 2011 Sep;60(3):554-63. doi: 10.1016/j.eururo.2011.05.047. Epub 2011 Jun 1.

PMID:
21664039
10.

The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.

Varenhorst E, Garmo H, Holmberg L, Adolfsson J, Damber JE, Hellström M, Hugosson J, Lundgren R, Stattin P, Törnblom M, Johansson JE.

Scand J Urol Nephrol. 2005;39(2):117-23.

PMID:
16019764
11.

[Androgen deprivation therapy and morbid obesity: do they share cardiovascular risk through metabolic syndrome?].

Cleffi S, Neto AS, Reis LO, Maia P, Fonseca F, Wroclawski ML, Neves M, Pompeo AC, Del Giglio A, Faria EF, Tobias-Machado M.

Actas Urol Esp. 2011 May;35(5):259-65. doi: 10.1016/j.acuro.2011.01.011. Epub 2011 Apr 2. Spanish.

PMID:
21459486
12.

[Social gradient of PSA screening? 8 years follow up from the cancer registry of the tumor center in Regensburg].

Klotz T, Mathers MJ, Gerken M, Klinkhammer-Schalke M, Hofstädter F.

Urologe A. 2010 Dec;49(12):1503-7. doi: 10.1007/s00120-010-2425-2. German.

PMID:
20945060
13.

PCBaSe Sweden: a register-based resource for prostate cancer research.

Hagel E, Garmo H, Bill-Axelson A, Bratt O, Johansson JE, Adolfsson J, Lambe M, Stattin P.

Scand J Urol Nephrol. 2009;43(5):342-9. doi: 10.3109/00365590903024577.

PMID:
19921977
14.

Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.

Bratt O, Garmo H, Adolfsson J, Bill-Axelson A, Holmberg L, Lambe M, Stattin P.

J Natl Cancer Inst. 2010 Sep 8;102(17):1336-43. doi: 10.1093/jnci/djq265. Epub 2010 Aug 19.

PMID:
20724726
15.

Incidence and mortality of incidental prostate cancer: a Swedish register-based study.

Andrèn O, Garmo H, Mucci L, Andersson SO, Johansson JE, Fall K.

Br J Cancer. 2009 Jan 13;100(1):170-3. doi: 10.1038/sj.bjc.6604834. Epub 2008 Dec 16.

16.

Adverse effects of androgen deprivation and the limits of national tumor registries.

Cooperberg MR.

Eur Urol. 2012 Apr;61(4):701-3; discussion 703-4. doi: 10.1016/j.eururo.2011.11.034. Epub 2011 Nov 30. No abstract available.

17.

Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.

Stattin P, Johansson R, Damber JE, Hellström M, Hugosson J, Lundgren R, Varenhorst E, Johansson JE.

Scand J Urol Nephrol. 2003;37(6):461-5.

PMID:
14675917
18.

Fracture risk in Danish men with prostate cancer: a nationwide register study.

Abrahamsen B, Nielsen MF, Eskildsen P, Andersen JT, Walter S, Brixen K.

BJU Int. 2007 Oct;100(4):749-54.

19.

Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden.

Berglund A, Garmo H, Tishelman C, Holmberg L, Stattin P, Lambe M.

J Urol. 2011 Mar;185(3):833-9. doi: 10.1016/j.juro.2010.10.061. Epub 2011 Jan 15.

PMID:
21239002
20.

Supplemental Content

Support Center